Meet the 92-year-old entrepreneur who has amassed a staggering net worth of Rs 27,500 crore, owning an impressive 71 hospitals and 5000 pharmacies, and still reports to his office every day.
Meet Dr. Prathap C. Reddy, a 92-year-old cardiologist and founder of the Apollo Hospitals chain, a multinational hospital network headquartered in Chennai, India. With a net worth of approximately Rs 27,500 crore, Dr. Reddy is a remarkable individual who has dedicated his life to providing world-class healthcare to the people of India and beyond. Despite his advanced age, he still works in his office every day from 10 AM to 5 PM, a testament to his passion and commitment to his work.
Dr. Reddy’s journey began when he received his medical degree from Stanley Medical College in Chennai and later trained as a cardiologist in the UK and USA. He worked in several research programs in the USA before returning to India in 1971 at the behest of his father. In 1983, he started the Apollo Health Chain with a 150-bedded hospital, which has since grown into a network of over 10,000 beds across 64 hospitals in India and overseas.
Under Dr. Reddy’s leadership, the Apollo Hospitals Group has become one of the largest hospital groups in the world, with over 4,000 top-class clinicians and a total employee strength of more than 65,000 professionals. The group has established around 6,000 pharmacies, 2,000 retail touchpoints, and has over 25 million registered users on its digital platform, Apollo 24/7. Dr. Reddy’s empire also includes 5,000 pharmacy outlets, making him one of the most successful healthcare entrepreneurs in India.
What’s remarkable about Dr. Reddy is that he has built his healthcare empire from scratch, with a vision to provide quality healthcare to the people of India. His dedication and hard work have paid off, and today, the Apollo Hospitals Group is a household name in India and a benchmark for quality healthcare. Despite his vast wealth and success, Dr. Reddy remains committed to his work, and his daily routine is a testament to his passion for providing healthcare to those in need.
Dr. Reddy’s story is an inspiration to many, and his legacy will continue to inspire future generations of healthcare professionals and entrepreneurs. His commitment to his work and his dedication to providing quality healthcare to the people of India have made him a truly remarkable individual, and his name has become synonymous with excellence in healthcare.
Apitoria Pharma Pvt Ltd introduces Auro Astra, a post-graduation certification program in leadership, in partnership with IMT Hyderabad.
Apitoria Pharma Pvt Ltd, a renowned pharmaceutical company, has partnered with the Institute of Management Technology (IMT) Hyderabad to launch a unique post-graduation certification program called Auro Astra. This innovative program is designed to equip professionals with essential leadership skills, enabling them to excel in their respective fields.
Auro Astra is a comprehensive certification program that focuses on developing leadership competencies, strategic thinking, and problem-solving skills. The program is tailored to cater to the needs of working professionals, providing them with a flexible and interactive learning experience. The certification program is set to commence soon, and applications are now open for interested candidates.
The collaboration between Apitoria Pharma and IMT Hyderabad brings together the expertise of a leading pharmaceutical company and a prestigious management institution. IMT Hyderabad is known for its academic excellence, research-oriented approach, and strong industry connections. Apitoria Pharma, with its extensive experience in the pharmaceutical sector, will provide valuable insights and practical knowledge to the participants.
The Auro Astra program is designed to bridge the gap between academic knowledge and industry requirements. It will cover a range of topics, including leadership, strategy, innovation, and entrepreneurship. The program will feature a mix of lectures, case studies, group discussions, and project work, ensuring that participants gain a holistic understanding of leadership principles and their application in real-world scenarios.
Upon completion of the program, participants will be awarded a post-graduation certification from IMT Hyderabad, recognizing their expertise in leadership. The certification will not only enhance their career prospects but also provide them with a competitive edge in the industry. The program is open to working professionals from various backgrounds, including pharmaceuticals, healthcare, and related fields.
The launch of Auro Astra is a significant step towards developing leadership talent in the pharmaceutical and healthcare sectors. With the increasing demand for skilled professionals, this program is expected to fill the gap by providing a comprehensive and practical learning experience. Apitoria Pharma and IMT Hyderabad are committed to delivering a world-class program that will empower participants to become effective leaders and make a meaningful impact in their respective organizations.
The partnership between Apitoria Pharma and IMT Hyderabad is a testament to the growing need for industry-academia collaboration. By combining their expertise and resources, they aim to create a pool of talented leaders who can drive innovation, growth, and success in the pharmaceutical and healthcare industries. With Auro Astra, Apitoria Pharma and IMT Hyderabad are poised to make a significant contribution to the development of leadership talent in these sectors.
Mankind Pharma appoints Dapinder Singh Narula as new Head of Talent Management, reports People Matters.
Dapinder Singh Narula has been appointed to lead the Talent Management function at Mankind Pharma, a leading Indian pharmaceutical company. In this exclusive interview with People Matters, Narula shared his vision and strategies for talent management in the organization.
With over 15 years of experience in HR, Narula has previously worked with companies like Ranbaxy, Pfizer, and Dr. Reddy’s Laboratories. He has a strong background in talent management, organizational development, and leadership development. At Mankind Pharma, Narula will be responsible for designing and implementing strategies to attract, retain, and develop talent across the organization.
Narula emphasized the importance of talent management in driving business growth and success. He stated that the pharmaceutical industry is highly competitive, and having the right talent is crucial to staying ahead of the curve. He plans to focus on creating a talent pipeline that is aligned with the organization’s business strategy and goals.
To achieve this, Narula will be working on several initiatives, including developing a comprehensive talent management framework, creating a leadership development program, and implementing a performance management system. He will also be focusing on building a strong employer brand to attract top talent to the organization.
Narula also highlighted the importance of digitalization in talent management. He believes that technology can play a key role in enhancing the employee experience, streamlining processes, and providing insights to inform talent decisions. He plans to leverage digital platforms to create a more engaging and personalized experience for employees.
Narula’s appointment is seen as a significant move by Mankind Pharma to prioritize talent management and invest in its people. The company has been growing rapidly, and having the right talent in place will be critical to its continued success. With Narula at the helm of talent management, Mankind Pharma is well-positioned to attract, retain, and develop the talent it needs to drive business growth and stay competitive in the industry.
Overall, Narula’s vision for talent management at Mankind Pharma is focused on creating a strategic approach to talent acquisition, development, and retention. By leveraging technology, building a strong employer brand, and creating a comprehensive talent management framework, Narula aims to drive business success and establish Mankind Pharma as a leader in the pharmaceutical industry.
Amit Patel has been promoted to lead Consumer Marketing Excellence as its new Head.
Amit Patel has been promoted to Head of Consumer Marketing Excellence at Cipla India, a leading pharmaceutical company. In his new role, Patel will be responsible for driving consumer marketing across various therapeutic areas, with a focus on building patient-centric and insight-led narratives. He expressed his excitement and gratitude for the opportunity, reflecting on his journey so far and the impact of his previous campaigns, which aimed to shift perceptions, build awareness, and create connections between patients and therapies.
Patel has over 15 years of experience in marketing and brand strategy, having worked across geographies and industries. Prior to joining Cipla, he held key positions at several companies, including Dabur International Ltd, VLCC International LLC, and Karan Communications, where he began his career as a Creative Coordinator. His professional strengths include critical thinking, public relations, digital marketing, brand development, and strategic planning.
As Head of Consumer Marketing Excellence, Patel will leverage his expertise to drive impactful and purpose-driven ideas at scale. He is committed to strengthening Cipla’s commitment to building patient-centric narratives and contributing to the company’s legacy of caring for life. Patel’s promotion is a testament to his hard work and dedication, and he is looking forward to the new challenges and opportunities that his expanded role will bring.
Patel’s experience and skills will be valuable assets to Cipla as the company continues to navigate the evolving healthcare landscape. His ability to think critically and develop effective marketing strategies will help drive growth and innovation in the company’s consumer marketing efforts. With his new role, Patel is poised to make a significant impact at Cipla and contribute to the company’s mission of improving the lives of patients and communities. Overall, Patel’s promotion is a significant development for Cipla, and his expertise and leadership will be instrumental in shaping the company’s consumer marketing efforts in the years to come.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.